Xiabin Jing Selected Research

poly(lactide) (polylactic acid)

1/2016	Antitumor activity of electrospun polylactide nanofibers loaded with 5-fluorouracil and oxaliplatin against colorectal cancer.
7/2015	Use of asymmetric multilayer polylactide nanofiber mats in controlled release of drugs and prevention of liver cancer recurrence after surgery in mice.
6/2015	The use of cisplatin-loaded mucoadhesive nanofibers for local chemotherapy of cervical cancers in mice.
1/2015	Metabolism targeting therapy of dichloroacetate-loaded electrospun mats on colorectal cancer.
1/2013	Inhibition of orthotopic secondary hepatic carcinoma in mice by doxorubicin-loaded electrospun polylactide nanofibers.
6/2012	Necrosis of cervical carcinoma by dichloroacetate released from electrospun polylactide mats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiabin Jing Research Topics

Disease

64	Neoplasms (Cancer) 12/2021 - 09/2006
9	Carcinoma (Carcinomatosis) 01/2017 - 06/2012
6	Liver Neoplasms (Liver Cancer) 10/2020 - 03/2010
5	Glioma (Gliomas) 11/2015 - 09/2006
3	Wounds and Injuries (Trauma) 01/2021 - 05/2009
3	Hepatocellular Carcinoma (Hepatoma) 12/2015 - 01/2014
3	Ovarian Neoplasms (Ovarian Cancer) 08/2015 - 08/2010
2	Colonic Neoplasms (Colon Cancer) 11/2016 - 12/2012
2	Margins of Excision 10/2016 - 07/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 01/2015
2	Breast Neoplasms (Breast Cancer) 08/2015 - 04/2015
2	Lung Neoplasms (Lung Cancer) 11/2011 - 01/2011
1	Infections 01/2021
1	Wound Infection (Wound Infections) 01/2021
1	Hypoxia (Hypoxemia) 12/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017
1	Hypoglycemia (Reactive Hypoglycemia) 01/2017
1	Body Weight (Weight, Body) 12/2015
1	Brain Neoplasms (Brain Tumor) 11/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2015
1	Ischemia 09/2014
1	Anemia 09/2014
1	Neoplasm Metastasis (Metastasis) 01/2014

Drug/Important Bio-Agent (IBA)

24	Pharmaceutical PreparationsIBA 01/2018 - 01/2009
24	MicellesIBA 03/2017 - 10/2009
15	PolymersIBA 11/2016 - 01/2011
11	Paclitaxel (Taxol)FDA LinkGeneric 10/2021 - 02/2007
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017 - 03/2012
10	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 10/2011
9	ProdrugsIBA 12/2021 - 01/2014
7	Folic Acid (Vitamin M)FDA LinkGeneric 08/2015 - 11/2009
6	poly(lactide) (polylactic acid)IBA 01/2016 - 06/2012
5	PlatinumIBA 01/2017 - 06/2013
5	methylallyl trisulfide (MATS)IBA 10/2016 - 06/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2015
3	CarbonIBA 10/2020 - 11/2015
3	Coloring Agents (Dyes)IBA 11/2016 - 07/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2015 - 01/2013
3	AcidsIBA 11/2015 - 11/2012
3	LigandsIBA 08/2014 - 10/2009
2	Metal-Organic FrameworksIBA 01/2021 - 11/2016
2	DNA AdductsIBA 01/2017 - 02/2016
2	Small Interfering RNA (siRNA)IBA 01/2017 - 12/2009
2	Therapeutic UsesIBA 11/2016 - 12/2015
2	DisulfidesIBA 06/2016 - 09/2013
2	1,2-cyclohexanediamine (dach)IBA 04/2016 - 03/2012
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 11/2012
1	EnzymesIBA 12/2021
1	UCON 50-HB-5100 (F127)IBA 10/2021
1	Human Serum Albumin FDA LinkGeneric 10/2021
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 10/2021
1	Tannic Acid FDA Link 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Photosensitizing Agents (Photosensitizers)IBA 12/2020
1	phytochlorinIBA 12/2020
1	Peptides (Polypeptides)IBA 12/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2020
1	HafniumIBA 10/2020
1	Messenger RNA (mRNA)IBA 01/2017
1	GuanosineIBA 01/2017
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2017
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 10/2016
1	Oxygen (Dioxygen)IBA 04/2016
1	Copper Transport ProteinsIBA 02/2016
1	transplatinIBA 01/2016
1	Fluorouracil (Carac)FDA LinkGeneric 01/2016
1	BoronIBA 12/2015
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 12/2015
1	Glutamic Acid (Glutamate)FDA Link 11/2015
1	Aspartic Acid (Aspartate)FDA Link 11/2015
1	Dextrans (Dextran)FDA Link 11/2015
1	diammine(dichloroacetato)platinum(II)IBA 08/2015
1	Ethylene Oxide (Oxirane)IBA 06/2015
1	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 04/2015
1	Dichloroacetic AcidIBA 01/2015
1	diisopropylamine dichloroacetate (DIPA)IBA 01/2015
1	Hemoglobins (Hemoglobin)IBA 09/2014
1	Antineoplastic Agents (Antineoplastics)IBA 09/2014
1	imidazoleIBA 08/2014
1	Lactose FDA LinkGeneric 04/2014
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 04/2014
1	Polysaccharides (Glycans)IBA 04/2014
1	HydrogelsIBA 02/2014
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2014
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2014
1	caprolactoneIBA 09/2013
1	Ethylene Glycol (Monoethylene Glycol)IBA 09/2013

Therapy/Procedure

22	Therapeutics 12/2021 - 05/2009
16	Drug Therapy (Chemotherapy) 12/2021 - 09/2006
5	Lasers (Laser) 01/2021 - 12/2012
3	Photothermal Therapy 11/2016 - 09/2016
2	Intravenous Administration 03/2017 - 01/2012
2	Combination Drug Therapy (Combination Chemotherapy) 01/2015 - 06/2013
1	Photochemotherapy (Photodynamic Therapy) 12/2020
1	Immunotherapy 01/2020
1	Precision Medicine 09/2016
1	Induced Hyperthermia (Thermotherapy) 03/2016
1	Intravenous Injections 01/2016
1	Resuscitation 09/2014